A Study to Evaluate SimPull for Lateral Patient Transfer
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 22-004929
NCT ID: NCT05856123
About this study
The primary objective of this study is to utilize SimPull as an alternative to current lateral patient transfer methods, evaluating if SimPull is feasible as a primary means of lateral patient transfer.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients requiring lateral transfer for an invasive cardiac procedure to and from
gurney to exam table.
- Patients requiring lateral transfer for an invasive cardiac procedure to and from exam
table to gurney.
- Patient does not have compound fractures or cervical fractures present.
- Patient does not have skin damage or open wounds to the dorsal cavity.
- Patient or legally authorized representative (LAR) must be able/present to sign
consent.
Exclusion Criteria:
- Patients who do not require lateral transfer for an invasive cardiac procedure to and
from gurney to exam table.
- Patients who do not require lateral transfer for an invasive cardiac procedure to and
from exam table to gurney.
- Patient has compound fractures or cervical fractures present.
- Patient has skin damage or open wounds to the dorsal cavity.
- Patient or legally authorized representative (LAR) are unable/present to sign consent.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 2/12/2024. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Deanna Covelli, M.S.N., R.N. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available